Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient.

Deborah EshaghKhadija BenaliAntoine DossierMarie Paule ChauveheidDiane RouzaudTiphaine GoulenokThomas PapoKarim Sacre

Published in: Infection (2020)

In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.

Keyphrases

mycobacterium tuberculosis
human immunodeficiency virus
antiretroviral therapy
hiv infected patients
case report
hiv aids
hiv infected
hepatitis c virus
pulmonary tuberculosis
oxidative stress
hiv positive
ulcerative colitis